Brief: Theranexus End-December Total Available Funds At 9.14 Mln Euros
Jan 18 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER
2022
AND ANNOUNCES ORGANIZATIONAL CHANGES
* ON 31 DECEMBER 2022, TOTAL AVAILABLE FUNDS STOOD AT EUR
9.14 M
COMPARED WITH EUR11.00 M ON 30 SEPTEMBER 2022
* BOARD OF DIRECTORS HAS APPOINTED MATHIEU CHARVÉRIAT AS CEO
* BOARD OF DIRECTORS HAS APPOINTED FRANCK MOUTHON AS
EXECUTIVE
CHAIRMAN
Source text for Eikon: ID:nACT78081
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease